Targeted Metabolomics

We develop improved diagnostic testing for conditions related to metabolic dysfunction, including chronic kidney, liver and cardiac diseases.

Learn more

NMR Metabolomics

From a single serum sample, we quantify multiple biomarkers, known and newly discovered. Precision Diagnostics.

AXINON® System

Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.

Learn more

Precision Diagnostics

AXINON® System, Using FDA-Cleared Technology

Numares Health develops advanced biomarker tests to diagnose and measure disease progression for conditions related to metabolic dysfunction, such as chronic kidney, liver and cardiac diseases. 

We use nuclear magnetic resonance (NMR) spectroscopy to quantify multiple biomarkers — known and newly discovered — from a single serum sample. Machine learning then identifies the few, specific metabolites relevant to diagnosis.

The AXINON® System, using FDA-cleared technology, is our core technology platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy.

  • The FDA-cleared AXINON® LDL-p Test System, is a new tool physicians can use to measure lipoproteins for patients at risk for cardiovascular disease.

  • Currently, Numares is the only company in the US selling an FDA-cleared NMR test.


Personalized Risk Assessment. Multiplexed Metabolomics.

Cardiology

AXINON® LDL-p Test System: Now FDA-cleared, provides more detailed information about cardiac function than the standard LDL-C (low-density lipoprotein or “bad cholesterol”) measurement.

AXINON® lipoFIT®: For cardiovascular risk assessment.

Available as a CE-labled in vitro diagnostic product in the EU 

Nephrology

AXINON® GFR(NMR): New kidney function assay that combines two novel biomarkers, valine and myo-inositol, with creatinine and cystatin C using highly accurate nuclear magnetic resonance (NMR) spectroscopy.

Available as a CE-labled in vitro diagnostic product in the EU and as a research-use-only product in the US.

Hepatology

AXINON® HCC(NMR): Liver risk assessment and cancer early detection test.

In development.



You did not activate the necessary cookies for this content.

activate necessary cookies and show content